As for NAFLD, a previous meta-analysis conducted by Zhang et al. 46, evaluated the association between APOC3 polymorphisms and risk of NAFLD based on 7 studies and reported that the APOC3 gene polymorphism is not a genetic risk factor for NAFLD. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.